Eileen Rakovitch, MD, associate professor, radiation oncologist, Sunnybrook Health Sciences Centre, Toronto, Ontario, discusses predicting risk of recurrence in women with DCIS.
Clinical Pearls
Eileen Rakovitch, MD, associate professor, radiation oncologist, Sunnybrook Health Sciences Centre, Toronto, Ontario, discusses predicting risk of recurrence in women with DCIS.
Oncotype DX DCIS Score was validated as a predictor of risk of recurrence among women treated with breast-conserving surgery alone for DCIS.
Women with a low-risk DCIS Score had a significantly lower risk of recurrence.
Every 50 point increase in DCIS Score was associated with a two-fold increase in risk of recurrence.
